Ad26.Mos4.HIV

Adenovirus serotype 26 HIV vaccine (Mosaic) · Janssen Vaccines & Prevention B.V.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Ad26.Mos4.HIV, covering 2023-04-18 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults [Phase 1, Phase 2]

See pricing